Grace Therapeutics, Inc. (ACST)
2.12
+0.02
(+0.95%)
USD |
NASDAQ |
Sep 08, 16:00
Grace Therapeutics Price to Book Value : 0.7156 for Sept. 8, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 0.7156 |
| September 04, 2026 | 0.7089 |
| September 03, 2026 | 0.7224 |
| September 02, 2026 | 0.7224 |
| September 01, 2026 | 0.7089 |
| August 31, 2026 | 0.719 |
| August 28, 2026 | 0.7156 |
| August 27, 2026 | 0.7291 |
| August 26, 2026 | 0.7257 |
| August 25, 2026 | 0.7426 |
| August 24, 2026 | 0.7359 |
| August 21, 2026 | 0.7426 |
| August 20, 2026 | 0.7224 |
| August 19, 2026 | 0.7426 |
| August 18, 2026 | 0.719 |
| August 17, 2026 | 0.7291 |
| August 14, 2026 | 0.7291 |
| August 13, 2026 | 0.6987 |
| August 12, 2026 | 0.7089 |
| August 11, 2026 | 0.7156 |
| August 10, 2026 | 0.7122 |
| August 07, 2026 | 0.719 |
| August 06, 2026 | 0.7156 |
| August 05, 2026 | 0.7224 |
| August 04, 2026 | 0.7359 |
| Date | Value |
|---|---|
| August 03, 2026 | 0.7021 |
| July 31, 2026 | 0.7021 |
| July 30, 2026 | 0.6987 |
| July 29, 2026 | 0.7021 |
| July 28, 2026 | 0.7595 |
| July 27, 2026 | 0.7764 |
| July 24, 2026 | 0.7865 |
| July 23, 2026 | 0.7933 |
| July 22, 2026 | 0.80 |
| July 21, 2026 | 0.8203 |
| July 20, 2026 | 0.8203 |
| July 17, 2026 | 0.8338 |
| July 16, 2026 | 0.8135 |
| July 15, 2026 | 0.8203 |
| July 14, 2026 | 0.8304 |
| July 13, 2026 | 0.8203 |
| July 10, 2026 | 0.827 |
| July 09, 2026 | 0.8236 |
| July 08, 2026 | 0.8405 |
| July 07, 2026 | 0.8473 |
| July 06, 2026 | 0.854 |
| July 02, 2026 | 0.80 |
| July 01, 2026 | 0.7561 |
| June 30, 2026 | 0.7663 |
| June 29, 2026 | 0.5768 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AbbVie, Inc. | -- |
| Abeona Therapeutics, Inc. | 2.614 |
| America Great Health | -- |
| Acumen Pharmaceuticals, Inc. | 3.991 |
| Aardvark Therapeutics, Inc. | 1.560 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0411 |
| Price | 2.12 |
| Earnings Yield | -55.82% |
| Market Cap | 34.50M |
| PEGY Ratio | -0.0411 |